52747-711 NDC - INTEGRA F (FERROUS FUMARATE AND POLYSACCHRIDE IRON COMPLEX AND FOLIC ACID)

Drug Information

Product NDC: 52747-711

Proprietary Name: Integra F

Non Proprietary Name: Ferrous Fumarate and Polysacchride Iron Complex and Folic Acid

Active Ingredient(s):
  • 40 mg/1 ASCORBIC ACID;
  • 62.5 mg/1 FERROUS ASPARTO GLYCINATE;
  • 62.5 mg/1 FERROUS FUMARATE;
  • 1 mg/1 FOLIC ACID;
  • 3 mg/1 NIACIN


Administration Route(s): ORAL

Dosage Form(s): CAPSULE

Pharmacy Class(es):
  • Ascorbic Acid [CS];
  • Nicotinic Acid [EPC];
  • Nicotinic Acids [CS];
  • Vitamin C [EPC]

Labeler Information

Labeler Name: U.S. Pharmaceutical Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date:4/27/2009

Package Information

No. Package Code Package Description Billing Unit
152747-711-3030 CAPSULE in 1 BOTTLE, PLASTIC (52747-711-30)EA
252747-711-6090 CAPSULE in 1 BOTTLE, PLASTIC (52747-711-60)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC52747-711The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEIntegra FThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEFerrous Fumarate and Polysacchride Iron Complex and Folic AcidThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMECAPSULEThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE4/27/2009This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED DRUG OTHERProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEU.S. Pharmaceutical CorporationName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEASCORBIC ACID; FERROUS ASPARTO GLYCINATE; FERROUS FUMARATE; FOLIC ACID; NIACINAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH40; 62.5; 62.5; 1; 3 
ACTIVE INGRED UNITmg/1; mg/1; mg/1; mg/1; mg/1 
PHARM CLASSESAscorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin C [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023